These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24353409)

  • 1. Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin.
    Wang Z; Ge J
    Clin Interv Aging; 2014; 9():1-8. PubMed ID: 24353409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability.
    Crouse JR
    Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):287-304. PubMed ID: 18363544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
    McKenney JM
    Am J Health Syst Pharm; 2005 May; 62(10):1033-47. PubMed ID: 15901588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
    van der Lee M; Sankatsing R; Schippers E; Vogel M; Fätkenheuer G; van der Ven A; Kroon F; Rockstroh J; Wyen C; Bäumer A; de Groot E; Koopmans P; Stroes E; Reiss P; Burger D
    Antivir Ther; 2007; 12(7):1127-32. PubMed ID: 18018771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approximate equivalent rosuvastatin doses for temporary statin interchange programs.
    Kendrach MG; Kelly-Freeman M
    Ann Pharmacother; 2004; 38(7-8):1286-92. PubMed ID: 15187217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin: a review of its use in the management of dyslipidemia.
    Scott LJ; Curran MP; Figgitt DP
    Am J Cardiovasc Drugs; 2004; 4(2):117-38. PubMed ID: 15049723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin: a high-potency HMG-CoA reductase inhibitor.
    Lopez LM
    J Am Pharm Assoc (2003); 2005; 45(4):503-13. PubMed ID: 16128507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia.
    Riesen WF; Noll G; Dariolo R;
    Swiss Med Wkly; 2008 Jul; 138(29-30):420-6. PubMed ID: 18654867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.
    Kostapanos MS; Rizos CV; Elisaf MS
    Drug Saf; 2014 Jul; 37(7):481-500. PubMed ID: 24788803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rosuvastatin in the management of dyslipidemia.
    Rubba P; Marotta G; Gentile M
    Vasc Health Risk Manag; 2009; 5(1):343-52. PubMed ID: 19436657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin: a review of its effect on atherosclerosis.
    Keating GM; Robinson DM
    Am J Cardiovasc Drugs; 2008; 8(2):127-46. PubMed ID: 18422395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of atherosclerosis in patients living with HIV.
    De Lorenzo F; Boffito M; Collot-Teixeira S; Gazzard B; McGregor JL; Shotliff K; Xiao H
    Vasc Health Risk Manag; 2009; 5(1):287-300. PubMed ID: 19436663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.
    Ballantyne CM; Miller E; Chitra R
    Clin Ther; 2004 Nov; 26(11):1855-64. PubMed ID: 15639697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of efficacy of rosuvastatin 5 mg.
    Teramoto T; Watkins C
    Int J Clin Pract; 2005 Jan; 59(1):92-101. PubMed ID: 15707472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients.
    Yang J; Li LJ; Wang K; He YC; Sheng YC; Xu L; Huang XH; Guo F; Zheng QS
    Acta Pharmacol Sin; 2011 Jan; 32(1):116-25. PubMed ID: 21151159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of alternate day versus daily dosing of rosuvastatin.
    Dulay D; LaHaye SA; Lahey KA; Day AG
    Can J Cardiol; 2009 Feb; 25(2):e28-31. PubMed ID: 19214297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.
    Prescrire Int; 2004 Aug; 13(72):132-4. PubMed ID: 15532136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.